Last reviewed · How we verify

NCT05883774

Effects of rTMS on the Anxiety State of Older Patients With GAD

Not yet recruiting NA Last updated 2 October 2024
What this trial tests

NA trial testing Repetitive Transcranial Magnetic Stimulation in Generalized Anxiety Disorder in 100 participants. Not yet recruiting.

Timeline
1 December 2024
Primary endpoint
1 December 2025
1 December 2025

Quick facts

Lead sponsorYi Yang
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment100
Start date1 December 2024
Primary completion1 December 2025
Estimated completion1 December 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Yi Yang — full company profile →

Who can join

60 and older, any sex, with Generalized Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the effects of low-frequency repetitive transcranial magnetic stimulation on anxiety state in older patients with generalized anxiety disorder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Repetitive Transcranial Magnetic Stimulation

Trials testing the same drug.

Other recruiting trials for Generalized Anxiety Disorder

Currently open trials in the same condition.

Other Yi Yang trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05883774.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing